Medical Condition News

RSS

iCAD, Breastlink announce agreement to offer Xoft brachytherapy system

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, and Breastlink Medical Group in Southern California, today announced an agreement that will make the Xoft Axxent Electronic Brachytherapy System available to breast cancer patients treated at Breastlink.

5 May 2012

Clinical data from Anacor’s tavaborole and AN2728 study to be presented at upcoming meetings

Anacor Pharmaceuticals announced today that it will be presenting clinical data on its lead compounds, tavaborole and AN2728, at the following upcoming medical meetings.

5 May 2012

PDE4 enzyme regulates division of tumour cells and blood vessel growth in cancer tissue

Lung cancer is the leading cause of cancer death throughout the world. Standard treatment methods do not usually result in long-term recovery. In addition to the proliferation of the tumour cells, the growth of blood vessels controls tumors development. The blood vessel growth is controlled by several signalling molecules. Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim and Justus Liebig University Giessen have discovered a molecule that plays a key role in this process. They succeeded in reducing tumour growth in their experiments by blocking the phosphodiesterase PDE4.

5 May 2012

Sound Interventions completes ultrasound clinical trial on resistant hypertension

Sound Interventions, Inc. today announced the successful completion of the company's First-In-Human clinical trial (SOUND-ITV) to treat resistant hypertension.

5 May 2012

Ocular Therapeutix initiates travoprost-loaded punctum plug trial in glaucoma

Ocular Therapeutix, Inc. announced today the commencement of a sustained release travoprost-loaded punctum plug feasibility study for the treatment of glaucoma.

5 May 2012

LRI applauds ACR colleagues for new lupus nephritis guidelines

The Lupus Research Institute (LRI) applauds our colleagues at the American College of Rheumatology (ACR) for issuing new guidelines to help healthcare professionals screen, diagnose and treat lupus nephritis, a type of kidney disease associated with lupus. Available on the ACR website, the new guidelines are just published in the April 2012 issue of Arthritis Care & Research.

5 May 2012

CINJ nurses develop new teaching method to improve patient safety

Oncology nurses in the outpatient setting face constant challenges in the management of patient care, as many cancer patients receive therapies known to cause allergic reactions or hypersensitivity. When such emergencies arise, oncology nurses need to quickly, competently and safely manage these specific needs. In order to address such a scenario, nurses at The Cancer Institute of New Jersey (CINJ) have developed a teaching method to make mock situations more closely resemble real emergency events.

5 May 2012

Dilp8 provides an important signal to slow body growth and delay insect development

Two independent groups of researchers have identified a hormone that is responsible for keeping the growth and development of insects on track. The results, which are reported in the journal Science, suggest that Dilp8 provides an important signal to slow body growth and delay insect development.

5 May 2012

MicroRNAs in breast cancer play a role in development of resistance to tamoxifen

Many breast cancer patients are treated with a drug called tamoxifen. The substance blocks the effect of estrogen and thus suppresses the growth signals of this hormone in cancer cells. When resistance to the drug develops, tumor cells change their growth program: They change their behavior and shape, become more mobile and also adopt the ability to invade surrounding tissue. Scientists working with PD (Associate Professor) Dr. Stefan Wiemann of the German Cancer Research Center (DKFZ) have now also observed these changes in tamoxifen resistant breast cancer cells.

5 May 2012

Low levels of testosterone in men could increase risk of diabetes

Low levels of testosterone in men could increase their risk of developing diabetes, a study suggests.

5 May 2012

Pfizer terminates Lyrica Phase 3 trial on neuropathic pain associated with HIV neuropathy

Pfizer Inc. announced today that it has stopped a Phase 3 clinical trial of Lyrica (pregabalin) in patients with neuropathic pain associated with HIV neuropathy, a form of nerve damage characterized by burning pain usually beginning in the feet. The decision follows review of a planned interim analysis of the study by the trial's external Data Monitoring Committee.

5 May 2012

New research about why people forego colorectal cancer screening

New research about why people forego colorectal cancer (CRC) screening suggests that three fears play a significant role; fear of embarrassment, fear of getting AIDS and fear of pain may make some seniors skip the potentially lifesaving tests.

5 May 2012

Load-bearing sports may protect young men from osteoporosis

Young men who play volleyball, basketball or other load-bearing sports for four hours a week or more increase bone mass and might gain protection from developing osteoporosis later in life, according to a new study in the May issue of the Journal of Bone and Mineral Research.

5 May 2012

Isis commences ISIS-APOCIIIRx Phase 2 study in hypertriglyceridemia

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study evaluating ISIS-APOCIIIRx in patients with hypertriglyceridemia.

5 May 2012

Research roundup: Chronic disease interventions could save states money; Drilling into childhood cancer disparities; National heart emergency care system proposed

Urban Institute: Potential Savings Through Prevention Of Avoidable Chronic Illness Among CalPERS State Active Members -- California is one of many states in financial crisis, and according to this report, it could save millions of dollars on state employee health benefits by preventing chronic disease.

5 May 2012

Pfizer’s Lyrica Phase 3 study on pDPN fails to meet primary endpoint

Pfizer Inc. announced today that a Phase 3 randomized withdrawal design study for Lyrica (pregabalin) in patients with inadequately treated painful diabetic peripheral neuropathy (pDPN) did not meet its primary efficacy endpoint, change in endpoint mean pain score relative to baseline.

5 May 2012

Guidelines on cardiovascular disease prevention in clinical practice launched at EuroPRevent2012

The latest cardiovascular disease (CVD) prevention guidelines have been overhauled to produce a user friendly document with concise messages that awards greater weight than ever before to evidence from clinical trials and observational population studies. The "European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012)" - were launched at the EuroPRevent2012 meeting in Dublin, Ireland.

4 May 2012

Patterns of brain activity that play a role in recall of memories and decision-making

UCSF scientists have identified patterns of brain activity in the rat brain that play a role in the formation and recall of memories and decision-making. The discovery, which builds on the team's previous findings, offers a path for studying learning, decision-making and post-traumatic stress syndrome.

4 May 2012

Improved lung-cancer screening by combining blood test with CT imaging

National Jewish Health is seeking to refine and improve lung-cancer screening by combining a blood test with CT imaging to detect disease earlier and more effectively. The trial combines a CT chest scan and the EarlyCDT-Lung blood test to screen for cancer, and seeks to build on recent research demonstrating that CT screening alone can reduce lung-cancer mortality.

4 May 2012

Growing role of body image drugs

In the current issue of Psychotherapy and Psychosomatics Kanayama et al. analyse the growing role of body image drugs.

4 May 2012

Medical Condition News

iCAD, Breastlink announce agreement to offer Xoft brachytherapy system

Clinical data from Anacor’s tavaborole and AN2728 study to be presented at upcoming meetings

PDE4 enzyme regulates division of tumour cells and blood vessel growth in cancer tissue

Sound Interventions completes ultrasound clinical trial on resistant hypertension

Ocular Therapeutix initiates travoprost-loaded punctum plug trial in glaucoma

LRI applauds ACR colleagues for new lupus nephritis guidelines

CINJ nurses develop new teaching method to improve patient safety

Dilp8 provides an important signal to slow body growth and delay insect development

MicroRNAs in breast cancer play a role in development of resistance to tamoxifen

Low levels of testosterone in men could increase risk of diabetes

Pfizer terminates Lyrica Phase 3 trial on neuropathic pain associated with HIV neuropathy

New research about why people forego colorectal cancer screening

Load-bearing sports may protect young men from osteoporosis

Isis commences ISIS-APOCIIIRx Phase 2 study in hypertriglyceridemia

Research roundup: Chronic disease interventions could save states money; Drilling into childhood cancer disparities; National heart emergency care system proposed

Pfizer’s Lyrica Phase 3 study on pDPN fails to meet primary endpoint

Guidelines on cardiovascular disease prevention in clinical practice launched at EuroPRevent2012

Patterns of brain activity that play a role in recall of memories and decision-making

Improved lung-cancer screening by combining blood test with CT imaging

Growing role of body image drugs

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News